Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The longer big pharma waits the greater the chance they wili

<< Previous

Bullboard Posts

Next >>

Comment by Galaxym31on Jun 22, 2024 6:40pm

150 Views

Post# 36101885

RE:RE:The longer big pharma waits the greater the chance they wili

They big pharma dont need anything other than an ability to read to see the future at least put a couple of hundred million into it and get a first refusal . Keytruda 1.25 billion per year , horrible side effects .

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?